Antibiotics for infectious diseases play a pivotal role in modern medicine, representing a diverse class of medications that effectively combat bacterial infections. From the groundbreaking discovery of penicillin by Alexander Fleming to the present-day advancements in antibiotic research, these drugs have revolutionized healthcare and saved countless lives. Commonly used antibiotics include penicillins, cephalosporins, fluoroquinolones, tetracyclines, and macrolides, each with its unique mechanism of action and spectrum of activity. The fundamental principle behind antibiotics is their ability to target specific aspects of bacterial physiology, either inhibiting their growth or causing their destruction. This specificity allows for precision in treatment, but it also underscores the importance of accurate diagnosis to identify the causative bacteria. Different classes of antibiotics excel in treating specific types of infections, ranging from skin and respiratory infections to urinary tract and gastrointestinal infections. Despite their effectiveness, the overuse and misuse of antibiotics have led to a global health crisis: antibiotic resistance. Bacteria can develop resistance mechanisms, rendering antibiotics less effective or entirely ineffective. This phenomenon poses a significant threat to public health, emphasizing the need for judicious antibiotic prescribing practices and the development of new antibiotics to stay ahead of evolving bacterial resistance. Antimicrobial stewardship programs have emerged as a critical component in promoting responsible antibiotic use. These programs focus on optimizing the selection, dosage, and duration of antibiotic treatments, aiming to maximize therapeutic efficacy while minimizing the development of resistance. Healthcare professionals play a crucial role in adhering to these principles, considering factors such as the type of infection, patient characteristics, and local resistance patterns.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain